Amgen, Mustafa Nevzat Pharmaceuticals A/S deal

Amgen said it will acquire 95.6% of Mustafa Nevzat in a cash deal that values the Turkish pharma at $700 million. Mustafa Nevzat, which recorded about $200 million in 2011 revenue, manufactures and ma...